Statement From FDA Announcing New Draft Guidances On Medical Product Communications

On Wednesday January 18, 2017 Robert Califf the Commissioner of the U.S. Food & Drug Administration put out a statement saying that -- we recognize that there is a high level of interest regarding FDA's views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency's thinking on these issues. Today, the FDA released two separate draft guidances that will each help provide clarity for medical product companies, as well as other interested parties, on FDA's current thinking and recommendations for a few different types of communications about medical products. To learn more about FDA announcing new draft guidances on medical product communications click on the picture below to read the first and second draft guidance which will be published January 19, 2017.